More articles from Epigenetics

Tumor Hypoxia Suppresses TET Activity to Enhance DNA Methylation
Cancer Discovery Oct 2016, 6 (10) OF7; DOI: 10.1158/2159-8290.CD-RW2016-158
EZH2 Cooperates with BCL6 to Drive Lymphomagenesis
Cancer Discovery Oct 2016, 6 (10) OF8; DOI: 10.1158/2159-8290.CD-RW2016-153
Fumarate Promotes EMT by Downregulating Antimetastatic miRNAs
Cancer Discovery Oct 2016, 6 (10) 1081; DOI: 10.1158/2159-8290.CD-RW2016-169
DNMT3A and TET2 Cooperate and Compete to Maintain HSC DNA Methylation
Cancer Discovery Sep 2016, 6 (9) 944; DOI: 10.1158/2159-8290.CD-RW2016-143
ZMYND8 Cooperates with JARID1D to Suppress Metastatic Gene Expression
Cancer Discovery Sep 2016, 6 (9) OF7; DOI: 10.1158/2159-8290.CD-RW2016-145
Mutations in Histone H3K36 Prevent Methylation and Drive Sarcomagenesis
Cancer Discovery Jul 2016, 6 (7) 689; DOI: 10.1158/2159-8290.CD-RW2016-092
Disrupting Insulated Chromosome Neighborhoods Can Activate Oncogenes
Cancer Discovery Apr 2016, 6 (4) 343; DOI: 10.1158/2159-8290.CD-RW2016-045
Atypical Teratoid/Rhabdoid Tumors Encompass Three Epigenetic Subtypes
Cancer Discovery Apr 2016, 6 (4) 342; DOI: 10.1158/2159-8290.CD-RW2016-044
AML Fusions Require Epigenetic Modifiers to Transform Cells
Cancer Discovery Mar 2016, 6 (3) OF4; DOI: 10.1158/2159-8290.CD-RW2016-011
Focal Amplification of Super-Enhancers Upregulates Oncogenic Drivers
Cancer Discovery Feb 2016, 6 (2) 118; DOI: 10.1158/2159-8290.CD-RW2015-239

Main menu